Enlie Pharmaceutical JSC

Enlie Pharmaceutical JSC EBIT per Share

The EBIT per Share of Enlie Pharmaceutical JSC (BCP.VN) as of Oct 23, 2026 is 612.16 VND. In the previous year, EBIT per Share was -636.96 VND — a change of -196.11% (higher).

EBIT per Share

612.16VND

YoY

-196.11%

Last updated:

EBIT per Share of Enlie Pharmaceutical JSC is 2024 612.16 VND. EBIT per Share of Enlie Pharmaceutical JSC was 2023 -636.96 VND. It decreases by -196.11% higher compared to the previous year.

The Enlie Pharmaceutical JSC EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2017
2,105.75 VND
Jan 1, 2018
2,850.40 VND
Jan 1, 2019
-580.67 VND
Jan 1, 2020
-2,052.17 VND
Jan 1, 2021
-786.67 VND
Jan 1, 2022
298.54 VND
Jan 1, 2023
-636.96 VND
Jan 1, 2024
612.16 VND
The Enlie Pharmaceutical JSC EBIT per Share history
YEAREBIT per ShareYoY
612.16VND-196.11%
-636.96VND-313.36%
298.54VND-137.95%
-786.67VND-61.67%
-2,052.17VND+253.42%
-580.67VND-120.37%
2,850.40VND+35.36%
2,105.75VND+33.40%
1,578.50VND+35.55%
1,164.50VND-54.58%
2,564.00VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Enlie Pharmaceutical JSC Stock analysis

What does Enlie Pharmaceutical JSC do? Enlie Pharmaceutical JSC generates revenue primarily through the manufacture and commerce of pharmaceutical preparations, medical equipment, and health supplements. The company leverages its core expertise in these healthcare categories to serve the market, establishing its primary income streams around the production and sale of these essential health products. In addition to its pharmaceutical operations, the firm has diversified its business model by expanding into the real estate industry. This segment involves the development of various commercial and residential infrastructures which are then made available for lease, providing an additional layer of financial activity beyond its core healthcare focus. Enlie Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enlie Pharmaceutical JSC stock

EBIT per Share of Enlie Pharmaceutical JSC is 612.16 VND in 2024.

EBIT per Share of Enlie Pharmaceutical JSC changed from -636.96 VND to 612.16 VND, representing a -196.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Enlie Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Enlie Pharmaceutical JSC

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Enlie Pharmaceutical JSC